{"DataElement":{"publicId":"5781492","version":"1","preferredName":"Importance Weight Treatment Prednisone And/Or Dexamethasone Pill Importance Weight Type","preferredDefinition":"The text that describes the relative importance of prednisone and/or dexamethasone pills in treatment.","longName":"5781490v1.0:2479587v1.0","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"5781490","version":"1","preferredName":"Importance Weight Treatment Prednisone And/Or Dexamethasone Pill","preferredDefinition":"The text that describes the relative importance of prednisone and/or dexamethasone pills in treatment.","longName":"5781354v1.0:5781488v1.0","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"5781354","version":"1","preferredName":"Importance Weight","preferredDefinition":"The relative importance granted to something.","longName":"C48192","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Importance Weight","conceptCode":"C48192","definition":"The relative importance granted to something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DFD30AE-FEFB-69A4-E053-F662850A0816","latestVersionIndicator":"Yes","beginDate":"2017-04-25","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-25","modifiedBy":"ONEDATA","dateModified":"2017-04-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5781488","version":"1","preferredName":"Prednisone And/Or Dexamethasone Pill Dosage Form Treatment","preferredDefinition":"A synthetic glucocorticoid with anti-inflammatory and immunomodulating properties.  After cell surface receptor attachment and cell entry, prednisone enters the nucleus where it binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of proinflammatory cytokine production.  This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cell populations.:Used to indicate that either or both of two items or options may be valid.:A synthetic adrenal corticosteroid with potent anti-inflammatory properties. In addition to binding to specific nuclear steroid receptors, dexamethasone also interferes with NF-kB activation and apoptotic pathways. This agent lacks the salt-retaining properties of other related adrenal hormones. (NCI04):A solid composed of a small, round object composed of active and/or inert ingredient(s).:An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"5781488v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prednisone","conceptCode":"C770","definition":"A synthetic glucocorticoid with anti-inflammatory and immunomodulating properties.  After cell surface receptor attachment and cell entry, prednisone enters the nucleus where it binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of proinflammatory cytokine production.  This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cell populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Dexamethasone","conceptCode":"C422","definition":"A synthetic adrenal corticosteroid with potent anti-inflammatory properties. In addition to binding to specific nuclear steroid receptors, dexamethasone also interferes with NF-kB activation and apoptotic pathways. This agent lacks the salt-retaining properties of other related adrenal hormones. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pill Dosage Form","conceptCode":"C25394","definition":"A solid composed of a small, round object composed of active and/or inert ingredient(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Treatment","conceptCode":"C0087111","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DFEFCD8-FA7B-02E0-E053-F662850ADA78","latestVersionIndicator":"Yes","beginDate":"2017-04-25","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-25","modifiedBy":"ONEDATA","dateModified":"2017-04-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DFEFCD8-FA8C-02E0-E053-F662850ADA78","latestVersionIndicator":"Yes","beginDate":"2017-04-25","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-25","modifiedBy":"MORENOC","dateModified":"2017-07-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2479587","version":"1","preferredName":"Importance Weight Type","preferredDefinition":"The text that describes the relative importance of a factor.","longName":"2479587v1.0","context":"NIDCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not at all important","valueDescription":"Not at all important","ValueMeaning":{"publicId":"2578741","version":"1","preferredName":"Not at all important","longName":"2578741","preferredDefinition":"Not at all important","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-00A2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-25","endDate":null,"createdBy":"AYANLOWA","dateCreated":"2006-04-25","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13EED32E-993E-154C-E044-0003BA3F9857","beginDate":"2006-04-25","endDate":null,"createdBy":"AYANLOWA","dateCreated":"2006-05-16","modifiedBy":"AYANLOWA","dateModified":"2006-05-16","deletedIndicator":"No"},{"value":"Slightly important","valueDescription":"Slightly important","ValueMeaning":{"publicId":"2578742","version":"1","preferredName":"Slightly important","longName":"2578742","preferredDefinition":"Slightly important","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-00A3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-25","endDate":null,"createdBy":"AYANLOWA","dateCreated":"2006-04-25","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13EED32E-9953-154C-E044-0003BA3F9857","beginDate":"2006-04-25","endDate":null,"createdBy":"AYANLOWA","dateCreated":"2006-05-16","modifiedBy":"AYANLOWA","dateModified":"2006-05-16","deletedIndicator":"No"},{"value":"Moderately important","valueDescription":"Moderately important","ValueMeaning":{"publicId":"2578743","version":"1","preferredName":"Moderately important","longName":"2578743","preferredDefinition":"Moderately important","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-00A4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-25","endDate":null,"createdBy":"AYANLOWA","dateCreated":"2006-04-25","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13EED32E-9968-154C-E044-0003BA3F9857","beginDate":"2006-04-25","endDate":null,"createdBy":"AYANLOWA","dateCreated":"2006-05-16","modifiedBy":"AYANLOWA","dateModified":"2006-05-16","deletedIndicator":"No"},{"value":"very important","valueDescription":"very important","ValueMeaning":{"publicId":"2578744","version":"1","preferredName":"very important","longName":"2578744","preferredDefinition":"very important","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-00A5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-25","endDate":null,"createdBy":"AYANLOWA","dateCreated":"2006-04-25","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13EED32E-997D-154C-E044-0003BA3F9857","beginDate":"2006-04-25","endDate":null,"createdBy":"AYANLOWA","dateCreated":"2006-05-16","modifiedBy":"AYANLOWA","dateModified":"2006-05-16","deletedIndicator":"No"},{"value":"Extremely important","valueDescription":"Extremely important","ValueMeaning":{"publicId":"2578745","version":"1","preferredName":"Extremely important","longName":"2578745","preferredDefinition":"Extremely important","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-00A6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-25","endDate":null,"createdBy":"AYANLOWA","dateCreated":"2006-04-25","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13EED32E-9992-154C-E044-0003BA3F9857","beginDate":"2006-04-25","endDate":null,"createdBy":"AYANLOWA","dateCreated":"2006-05-16","modifiedBy":"AYANLOWA","dateModified":"2006-05-16","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"124B5135-CAD6-5425-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-25","endDate":null,"createdBy":"AYANLOWA","dateCreated":"2006-04-25","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Prednisone and/or dexamethaso","type":"Preferred Question Text","description":"Prednisone and/or dexamethasone pills","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DFF36CD-1D74-0443-E053-F662850A41A8","latestVersionIndicator":"Yes","beginDate":"2017-04-25","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-04-25","modifiedBy":"MORENOC","dateModified":"2017-07-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}